Lonza is doubling down on US and ADC expansion with its Merck CDMO deal
Lonza’s presence in Visp is also being expanded to support growing demand for ADC services.
Lonza’s presence in Visp is also being expanded to support growing demand for ADC services.
Anthropic hopes Powerful AI will “match or exceed the cognitive capabilities of top human experts across scientific disciplines”.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
How DFE Pharma supports confident continuous manufacturing decisions
Industry partnership will determine the success of the transition to low-GWP pMDIs